TOCQUEVILLE ASSET MANAGEMENT L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$382,148
-5.4%
4,266
-10.1%
0.01%0.0%
Q2 2023$404,074
-72.0%
4,746
-72.8%
0.01%
-74.1%
Q1 2023$1,442,084
-22.5%
17,427
-26.3%
0.03%
-22.9%
Q4 2022$1,859,679
+0.1%
23,645
-5.7%
0.04%
-7.9%
Q3 2022$1,857,000
-84.2%
25,080
-86.1%
0.04%
-82.2%
Q2 2022$11,721,000
+3.1%
179,8300.0%0.21%
+24.4%
Q1 2022$11,369,000
-8.7%
179,830
-23.4%
0.17%
+0.6%
Q4 2021$12,457,000
-2.8%
234,869
+29.3%
0.17%
-10.0%
Q3 2021$12,818,000
+2.5%
181,586
-3.2%
0.19%
+5.0%
Q2 2021$12,502,000
+372.1%
187,602
+686.5%
0.18%
+341.5%
Q1 2021$2,648,000
-11.0%
23,852
-4.8%
0.04%
-18.0%
Q4 2020$2,976,000
+35.5%
25,064
-0.5%
0.05%
+19.0%
Q3 2020$2,197,000
+72.7%
25,183
+77.4%
0.04%
+55.6%
Q2 2020$1,272,000
+159.1%
14,198
+247.7%
0.03%
+350.0%
Q2 2019$491,000
+21.8%
4,083
-11.5%
0.01%
+20.0%
Q1 2019$403,000
-16.4%
4,612
-4.3%
0.01%
-28.6%
Q4 2018$482,000
-8.0%
4,821
+5.4%
0.01%0.0%
Q3 2018$524,000
-94.0%
4,574
-98.3%
0.01%
-94.0%
Q3 2015$8,710,000
-21.0%
269,502
+1.1%
0.12%
-10.0%
Q2 2015$11,025,000
+0.7%
266,567
+9.4%
0.13%
+0.8%
Q1 2015$10,950,000
+265.6%
243,765
+204.6%
0.13%
+303.1%
Q4 2014$2,995,000
+38.9%
80,026
+29.6%
0.03%
+33.3%
Q3 2014$2,156,000
-1.6%
61,745
-0.5%
0.02%
+14.3%
Q2 2014$2,190,00062,0700.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders